ER stress sensor PERK promotes T cell pathogenicity in GVHD by regulating ER-associated degradation
Journal of Clinical Investigation · 01.12.2025 · 135 (23)
DOI: 10.1172/jci190958 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 30.09.2025. Verfasst von Qiao Cheng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology & Immunology and. Hauptthemen laut MEDLINE: eIF-2 Kinase, Graft vs Host Disease, Endoplasmic Reticulum Stress, CD8-Positive T-Lymphocytes. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NHLBI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Endoplasmic reticulum (ER) stress through IRE1/XBP1 is implicated in the onset and progression of graft-versus-host disease (GVHD), but the role of the ER stress sensor PERK in T cell allogeneic responses and GVHD remains unexplored. Here, we report that PERK is a key regulator in T cell allogeneic response and GVHD induction. PERK augments GVHD through increasing Th1 and Th17 population, while reducing Treg differentiation by activating the Nrf2 pathway. Genetic deletion or selective inhibition of PERK pharmacologically reduces GVHD while preserving graft-versus-leukemia (GVL) activity. At the cellular level, PERK positively regulates CD4 + T cell pathogenicity while negatively regulating CD8 + T cell pathogenicity in the induction of GVHD. At the molecular level, PERK interacts with SEL1L and regulates SEL1L expression, leading to augmented T cell allogeneic responses and GVHD development. In vivo, PERK deficiency in donor T cells alleviates GVHD through ER-associated degradation. Furthermore, pharmacological inhibition of PERK with AMG44 significantly suppresses the severity of GVHD induced by murine or human T cells. In summary, our findings validate PERK as a potential therapeutic target for the prevention of GVHD while preserving GVL responses, and uncover the mechanism by which PERK differentially regulates CD4 + versus CD8 + T cell allogeneic and antitumor responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology & Immunology and.
- Cancer Center, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
- Department of Pathology, Yale University, New Haven, Connecticut, USA.
- Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Förderung
- NCI NIH HHS
- NHLBI NIH HHS
- National Cancer Institute
- National Heart, Lung, and Blood Institute
Zitieren
APA
Cheng, Q., Choi, H. J., Wu, Y., Yuan, X., Pugel, A., Tian, L., Hendrix, M., Fu, D., Alimohammadi, R., Liu, C., & Yu, X. Z. (2025). ER stress sensor PERK promotes T cell pathogenicity in GVHD by regulating ER-associated degradation. Journal of Clinical Investigation, 135(23). https://doi.org/10.1172/jci190958
Vancouver
Cheng Q, Choi HJ, Wu Y, Yuan X, Pugel A, Tian L, et al. ER stress sensor PERK promotes T cell pathogenicity in GVHD by regulating ER-associated degradation. Journal of Clinical Investigation. 2025;135(23). doi:10.1172/jci190958
BibTeX
@article{Cheng2025,
author = {Cheng, Qiao and Choi, Hee-Jin and Wu, Yongxia and Yuan, Xiaohong and Pugel, Allison and Tian, Linlu and Hendrix, Michael and Fu, Denggang and Alimohammadi, Reza and Liu, Chen and Yu, Xue-Zhong},
title = {ER stress sensor PERK promotes T cell pathogenicity in GVHD by regulating ER-associated degradation},
journal = {Journal of Clinical Investigation},
year = {2025},
volume = {135},
number = {23},
doi = {10.1172/jci190958}
}
EUVIMED